share_log

HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target

Benzinga ·  Aug 11, 2023 07:25

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates IN8bio (NASDAQ:INAB) with a Buy and maintains $14 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment